![](/img/cover-not-exists.png)
Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Siegel, David S., Dimopoulos, Meletios A., Ludwig, Heinz, Facon, Thierry, Goldschmidt, Hartmut, Jakubowiak, Andrzej, San-Miguel, Jesus, Obreja, Mihaela, Blaedel, Julie, Stewart, A. KeithVolume:
36
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2017.76.5032
Date:
March, 2018
File:
PDF, 799 KB
2018